Evidence map›Paper›PMID 29467286›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Viral insulin-like peptides activate human insulin and IGF-1 receptor signaling: A paradigm shift for host-microbe interactions.

Emrah Altindis, Weikang Cai, Masaji Sakaguchi, Fa Zhang, Wang GuoXiao, Fa Liu, Pierre De Meyts, Vasily Gelfanov, Hui Pan, Richard DiMarchi and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 86 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. The Blood Virome: A new frontier in biomedical science.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2024
    Review
  11. Review
  12. Article
  13. vPIF-1 is an insulin-like antiferroptotic viral peptide.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  14. Article
  15. Review
  16. Article
  17. Urine microbiome in individuals with an impaired immune system.Frontiers in cellular and infection microbiology · 2023
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 4 countries.

Emrah AltindisJoslin Diabetes Center, Harvard Medical School, Boston, MA 02215.
Weikang CaiJoslin Diabetes Center, Harvard Medical School, Boston, MA 02215.
Masaji SakaguchiJoslin Diabetes Center, Harvard Medical School, Boston, MA 02215.
Fa ZhangDepartment of Chemistry, Indiana University, Bloomington, IN 47405.
Wang GuoXiaoJoslin Diabetes Center, Harvard Medical School, Boston, MA 02215.
Fa LiuDepartment of Chemistry, Indiana University, Bloomington, IN 47405.
Pierre De MeytsDepartment of Cell Signaling, de Duve Institute, B-1200 Brussels, Belgium.
Vasily GelfanovDepartment of Chemistry, Indiana University, Bloomington, IN 47405.
Hui PanJoslin Diabetes Center, Harvard Medical School, Boston, MA 02215.
Richard DiMarchiDepartment of Chemistry, Indiana University, Bloomington, IN 47405.
C Ronald KahnJoslin Diabetes Center, Harvard Medical School, Boston, MA 02215; c.ronald.kahn@joslin.harvard.edu.
Harvard University · USIndiana University Bloomington · USde Duve Institute · BEJoslin Diabetes Center · USKumamoto University · JP

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 1986 to 2026
$50.5M
INSULIN RECEPTOR STRUCTURE AND TURNOVERR37DK031036 · NIDDK · JOSLIN DIABETES CENTER · PI KAHN, C RONALD · 2000 to 2019
$12.9M
Insulin Receptor Substrates and Insulin ActionR01DK033201 · NIDDK · JOSLIN DIABETES CENTER · PI KAHN, C RONALD · 1986 to 2016
$10.6M
The Insulin Receptor and Its Signaling MechanismsR01DK031036 · NIDDK · JOSLIN DIABETES CENTER · PI C RONALD KAHN · 1986 to 2026
$4.2M
NIDDK NIH HHS P30 DK036836NIDDK NIH HHS R01 DK031036NIDDK NIH HHS R01 DK033201NIDDK NIH HHS R37 DK031036
6 · The paper itself

Abstract

Viruses are the most abundant biological entities and carry a wide variety of genetic material, including the ability to encode host-like proteins. Here we show that viruses carry sequences with significant homology to several human peptide hormones including insulin, insulin-like growth factors (IGF)-1 and -2, FGF-19 and -21, endothelin-1, inhibin, adiponectin, and resistin. Among the strongest homologies were those for four viral insulin/IGF-1-like peptides (VILPs), each encoded by a different member of the family

Indexed as

AnimalsCell LineCell ProliferationGlucoseHepatocytesHost-Pathogen InteractionsHumansInsulinInsulin-Like Growth Factor IMaleMiceMice, Inbred C57BLReceptor, IGF Type 1Signal TransductionViral ProteinsVirus DiseasesGlucoseInsulinInsulin-Like Growth Factor IReceptor, IGF Type 1Viral Proteinsdiabetesinsulininsulin-like growth factorviral hormonesviral pathogenesis

Identifiers

PMID29467286
PMCPMC5877943
OpenAlexW2789444527

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.